Clinical Trials
3 trialsNCT04660929 2024-12-18
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
Phase 1 Unknown
NCT02900664 2022-03-29
A Study of PDR001 in Combination With CJM112, EGF816, IlarisĀ® (Canakinumab) or MekinistĀ® (Trametinib)
Novartis
Phase 1 Completed
NCT00573495 2016-09-29
Multipeptide Vaccine for Advanced Breast Cancer
University of Pennsylvania
Phase 1 Completed